Update re. Completion of Software Sale

RNS Number : 6298I
Glantus Holdings PLC
05 December 2022
 

 

Glantus Holdings plc

 

(''Glantus'' or the ''Company'')

 

Update re. Completion of Software Sale

 

Glantus (AIM: GLAN), the provider of Accounts Payable ("AP") automation and analytics solutions, provides an update on the conditional software sale, detailed in the announcement made on 11 October 2022 (the "Software Sale"). The completion date for the Software Sale has now been extended to 12 December 2022. The Company has received £1.26m of the £1.40m consideration, with the balance of £0.14m expected to be paid on 14 December 2022.

 

 

Enquiries:

 

 

Glantus Holdings

 

Maurice Healy, CEO

Grainne McKeown, CFO

ir@glantus.com

 

+ 353 86 2677800 

Shore Capital  

 

Nominated Advisor and Broker

Patrick Castle / John More / Tom Knibbs (Corporate Advisory)

Andrew Beswick (Corporate Broking) 

 

+ 44 207 408 4090

Yellow Jersey PR

 

Charles Goodwin

Lilian Filips

Annabelle Wills

 

+44 7747 788 221

About Glantus Holdings plc

Glantus Holdings (AIM: GLAN) Glantus is a global provider of accounts payable automation and analytics solutions. Glantus' mission is to harness technology to drive innovation, unlocking efficiencies in AP to maximise working capital for global enterprise organisations. The award-winning Glantus DataShark Platform connects all AP systems and suppliers on one agile platform, eliminating cost and delivering new revenue streams. We work in tandem with our partners to deliver joint enterprise digital transformation solutions. For more information see   glantus.com  .

Founded in 2014 and headquartered in Dublin, Glantus has offices in the United States, United Kingdom, Poland and Costa Rica, employing over 120 people.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEADASELPAFFA
UK 100

Latest directors dealings